Lumateperone (ITI-007) for Schizophrenia
Lumateperone for Schizophrenia
Sponsor: Intra-Cellular Therapies
Enrolling: Male and Female Patients
Study Length: 199 Days
Clinic Visits: 12
IRB Number: 7716
U.S. Govt. ID: NCT03817528
Contact: Marlene Carlson, MPH: 646-774-8436 /
Additional Study Information: This study plans to learn more about an investigational new drug called lumateperone tosylate (ITI-007) and may help us find new types of treatment for schizophrenia and schizoaffective disorder.
This study is closed
Jeffrey Lieberman, MD
Do You Qualify?
Do you have schizophrenia or schizoaffective disorder? Yes No
Are you between the ages of 18-60? Yes No
Have you used another investigational medication in the previous 4 weeks? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Marlene Carlson, MPH